Oriana H. Yu
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The use of GLP-1 receptor agonists and co-agonists in adults without diabetes: a systematic review and network meta-analysis protocol.
Journal: Systematic reviews
Published: July 02, 2025
Mechanisms of GLP-1 Receptor Agonist-Induced Weight Loss: A Review of Central and Peripheral Pathways in Appetite and Energy Regulation.
Journal: The American journal of medicine
Published: January 23, 2025
Outcomes of SGLT-2i and GLP-1RA Therapy Among Patients With Type 2 Diabetes and Varying NAFLD Status.
Journal: JAMA network open
Published: December 28, 2023
Sodium-glucose Cotransporter-2 Inhibitors and Risk of Hepatocellular Carcinoma Among Patients With Type 2 Diabetes.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: October 30, 2022
Testosterone treatment and the risk of osteonecrosis: a pharmacovigilance analysis in Vigibase.
Journal: European journal of clinical pharmacology
Published: September 14, 2022
Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study.
Journal: BMJ (Clinical research ed.)
Published: September 24, 2020
Sodium-Glucose Cotransporter-2 Inhibitors and Severe Urinary Tract Infections: Reassuring Real-World Evidence.
Journal: Annals of internal medicine
Published: July 30, 2019
Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
Journal: BMJ (Clinical research ed.)
Published: December 07, 2018
Sulfonylureas as initial treatment for type 2 diabetes and the risk of adverse cardiovascular events: A population-based cohort study.
Journal: British journal of clinical pharmacology
Published: November 22, 2018
Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus.
Journal: JAMA internal medicine
Published: August 02, 2016
Pioglitazone use and risk of bladder cancer: population based cohort study.
Journal: BMJ (Clinical research ed.)
Published: April 01, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026